An FDA-proposed study on adolescents’ risk perceptions will help determine what kinds of drugs require special care in direct-to-consumer advertising directed at this patient population, the agency believes.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?